Research on Strategies for Treating Influenza A Virus Infection Based on the Theory of Wei Qi Ying Xue

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300078383

Enrollment

Unknown

Registered

2023-12-07

Start date

2023-11-28

Completion date

Unknown

Last updated

2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza A virus

Interventions

experimental group:Yinqiao Jingfang Decoction

control group:Tamiflu

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ?Those who meet the above diagnostic criteria; ?Clinically diagnosed as a patient with mild influenza A virus; ?Gender unlimited, age 18-65; ?Patients who voluntarily participate and sign informed consent forms.

Exclusion criteria

Exclusion criteria: ?Individuals with allergies or severe allergies to this type of medication; ?There are other virus infected individuals; ?Suffering from dementia or significant mental state changes that prevent them from understanding or expressing informed consent; ?Participants in other clinical trials;

Design outcomes

Primary

Measure	Time frame
Cure rate;Deterioration rate;	—

Secondary

Measure	Time frame
Traditional Chinese Medicine Syndrome Table;	—

Countries

China

Contacts

Public ContactChen Feng

The First Hospital of Jiaxing

cfly149@126.com+86 137 0573 1095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026